We are live on ! Find out more
TECX icon

Tectonic Therapeutic

66 hedge funds and large institutions have $268M invested in Tectonic Therapeutic in 2019 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 24 increasing their positions, 17 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

367% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 3

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

41% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 17

18% more funds holding

Funds holding: 56 → 66 (+10)

2.78% less ownership

Funds ownership: 71.35% → 68.57% (-2.8%)

29% less capital inflows, than outflows

Capital inflows: $30.3M | Capital outflows: $42.4M

Holders
66
Holders Change
+10
Holders Change %
+17.86%
% of All Funds
1.43%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.06%
New
14
Increased
24
Reduced
17
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

TECX Hedge Fund Activity: Q2 2019 in Review

66 of the 4,626 institutional investors tracked by Wall St. Rank reported a position in Tectonic Therapeutic (TECX) for Q2 2019, worth a combined $268M — down 29% from $379M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new TECX positions and 3 closed out — a net gain of 11 holders — while 24 added to existing stakes and 17 trimmed.

The largest buyer was PFM Health Sciences, opening a new position worth an estimated $4.48M. The largest seller was Blackstone, cutting an estimated $26.6M.

  • 66 institutional investors held Tectonic Therapeutic (TECX) as of Q2 2019, up from 56 in Q1 2019.
  • Funds reported $268M of Tectonic Therapeutic stock for Q2 2019, down 29% quarter-over-quarter.
  • 14 funds opened new Tectonic Therapeutic positions in Q2 2019 and 3 closed out, a net change of +11 holders.
  • The largest Tectonic Therapeutic buyer in Q2 2019 was PFM Health Sciences, an estimated $4.48M added.
  • The largest Tectonic Therapeutic seller in Q2 2019 was Blackstone, an estimated $26.6M sold.

Based on aggregated 13F filings for Q2 2019.